These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1825799)

  • 1. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation.
    Aspinall S; Kocks DJ
    S Afr Med J; 1998 Jan; 88(1):36-9. PubMed ID: 9539933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group.
    Lancet; 1989 May; 1(8646):1057-9. PubMed ID: 2566008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation of neonates at high risk of hepatitis B in England and Wales: national surveillance.
    Polakoff S; Vandervelde EM
    BMJ; 1988 Jul; 297(6643):249-53. PubMed ID: 2970879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
    Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H
    Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of hepatitis B immunization in the Expanded Program on Immunization of the Child Survival Project.
    Mansour E; Abdul-Rahim S; Batouty G; Zaghloul I; Abdel-Hadi S
    J Egypt Public Health Assoc; 1993; 68(5-6):487-94. PubMed ID: 7775876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
    JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses of adults, adolescents, and children to a plasma-derived hepatitis B vaccine in a rural African setting.
    Tabor E; Gerety RJ; Cairns J; Bayley AC
    J Med Virol; 1990 Oct; 32(2):134-8. PubMed ID: 2149145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B immunisation coverage of infants born to chronic carrier mothers in Victoria.
    Oman KM; Carnie J; Ruff T
    Aust N Z J Public Health; 1997 Dec; 21(7):731-4. PubMed ID: 9489190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea.
    Chung WK; Yoo JY; Sun HS; Lee HY; Lee IJ; Kim SM; Prince AM
    J Infect Dis; 1985 Feb; 151(2):280-6. PubMed ID: 3155778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey.
    Davaalkham D; Ojima T; Wiersma S; Lkhagvasuren T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y
    J Epidemiol Community Health; 2007 Jul; 61(7):578-84. PubMed ID: 17568048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo.
    Shindano TA; Mbusa RK; Kabamba BM; Fiasse R; Horsmans Y
    S Afr Med J; 2019 Apr; 109(5):319-322. PubMed ID: 31131798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of hepatitis B virus infection with vaccine in Japanese nursery schools.
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H
    Am J Epidemiol; 1987 Sep; 126(3):474-9. PubMed ID: 2956878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.